Literature DB >> 15604355

Clinical assessment of myocardial hibernation.

Arend F L Schinkel1, Jeroen J Bax, Don Poldermans.   

Abstract

Mesh:

Year:  2005        PMID: 15604355      PMCID: PMC1768620          DOI: 10.1136/hrt.2004.042085

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  31 in total

Review 1.  Chronic heart failure in the United States: a manifestation of coronary artery disease.

Authors:  M Gheorghiade; R O Bonow
Journal:  Circulation       Date:  1998-01-27       Impact factor: 29.690

2.  [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?

Authors:  G Srinivasan; A N Kitsiou; S L Bacharach; M L Bartlett; C Miller-Davis; V Dilsizian
Journal:  Circulation       Date:  1998-03-10       Impact factor: 29.690

3.  Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization.

Authors:  K Yoshida; K L Gould
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

4.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

5.  Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization.

Authors:  C G Cigarroa; C R deFilippi; M E Brickner; L G Alvarez; M A Wait; P A Grayburn
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

6.  Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography.

Authors:  R J Gropler; E M Geltman; K Sampathkumaran; J E Pérez; K B Schechtman; A Conversano; B E Sobel; S R Bergmann; B A Siegel
Journal:  J Am Coll Cardiol       Date:  1993-11-15       Impact factor: 24.094

7.  Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.

Authors:  F M Baer; E Voth; C A Schneider; P Theissen; H Schicha; U Sechtem
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

8.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors:  J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

9.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

10.  Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.

Authors:  V Dilsizian; T P Rocco; N M Freedman; M B Leon; R O Bonow
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

View more
  5 in total

1.  Non-invasive cardiac imaging technologies for the assessment of myocardial viability: a summary of evidence-based analyses.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-07-01

Review 2.  The indications and utility of adjunctive imaging modalities for chronic total occlusion (CTO) intervention.

Authors:  Usaid K Allahwala; Emmanouil S Brilakis; Hosen Kiat; Sally Ayesa; Daniel Nour; Michael Ward; Sidney Lo; James C Weaver; Ravinay Bhindi
Journal:  J Nucl Cardiol       Date:  2020-10-06       Impact factor: 5.952

3.  Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-07-01

4.  Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-07-01

5.  Myocardial viability: what we knew and what is new.

Authors:  Adel Shabana; Ayman El-Menyar
Journal:  Cardiol Res Pract       Date:  2012-09-05       Impact factor: 1.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.